Raul Monzon, MD
Interventional Pain Medicine · St Augustine, FLNPI 1508885286
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Elliquence, LLC accounts for 74.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $11,957 and has fallen 84.9% since, to $1,811 in 2025.
Across 71 payments — averaging $208.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elliquence, LLC$11K
- Boston Scientific$1K
- Stryker$500
- Abbott$412
- SPR Therapeutics, Inc$376
- Curonix LLC$251
- plus $780 from 10 others
What the payments were for
- Consulting fees$8,00054%
- Travel & lodging$3,36523%
- Food & beverage$3,38023%
- Education$410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elliquence, LLC | 12 | $11,031 |
| Boston Scientific | 18 | $1,436 |
| Stryker | 4 | $500 |
| Abbott | 6 | $412 |
| SPR Therapeutics, Inc | 6 | $376 |
| Curonix LLC | 6 | $251 |
| Nalu Medical, Inc. | 6 | $197 |
| Carlsmed, Inc. | 1 | $132 |
| AstraZeneca(2 entities) | 2 | $126 |
| Novo Nordisk | 1 | $108 |
| Stimwave Technologies Incorporated | 1 | $83 |
| Nevro Corp. | 3 | $53 |
| Medtronic(2 entities) | 2 | $33 |
| Neuros Medical, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $18 |
| Relievant Medsystems, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Disc-FX System$4,000
- mild Device Kit$301
- SPRINT PNS System$262
- Intracept$256
- GENERAL PAIN MANAGEMENT$171
- OPTABLATE$155
- Nalu Neurostimulation System$153
- PROCLAIM$150
- aprevo$132
- ETERNA$115
- Wegovy$108
How this compares
$14,786 in reported general payments places this provider in the 80th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 256 | $4,735 |
| Tramadol Hcl | 341 | $2,321 |
| Gabapentin | 204 | $2,044 |
| Fentanyl | 25 | $1,913 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $882 |
| Cephalexin | 104 | $740 |
| Celecoxib | 33 | $402 |
| Meloxicam | 80 | $314 |
| Pregabalin | 22 | $311 |
| Cyclobenzaprine Hcl | 43 | $299 |
| Omeprazole | 32 | $293 |
| Methylprednisolone | 25 | $207 |
| Baclofen | 18 | $186 |
| Zolpidem Tartrate | 24 | $183 |
| Duloxetine Hcl | 23 | $156 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in St Augustine
- Kassia SilvaSt Augustine$44K
- Joseph CartwrightSt Augustine$18K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.